Literature DB >> 23065452

Is there evidence for vasculitis in systemic sclerosis?

Lesley Ann Saketkoo1, Oliver Distler.   

Abstract

Systemic sclerosis (SSc) is a devastating and potentially life-threatening multi-organ system disease. SSc is marked by skin thickening and tightening, Raynaud's phenomenon and digital ischemia with ulceration, gastrointestinal dysmotility, cardiopulmonary involvement with pulmonary fibrosis and pulmonary arterial hypertension, as well as renal failure. Fibrosis is the most obvious manifestation of SSc. Vascular involvement and inflammation are other prominent components of SSc pathology, and both features are also seen in vasculitis. This review analyzes whether there is evidence for vasculitis especially with particular organ manifestations and subgroups of patients.

Entities:  

Mesh:

Year:  2012        PMID: 23065452     DOI: 10.1007/s11926-012-0296-9

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  77 in total

1.  Defective vasculogenesis in systemic sclerosis.

Authors:  Masataka Kuwana; Yuka Okazaki; Hidekata Yasuoka; Yutaka Kawakami; Yasuo Ikeda
Journal:  Lancet       Date:  2004 Aug 14-20       Impact factor: 79.321

2.  The plasminogen activator system in fibroblasts from systemic sclerosis.

Authors:  L Postiglione; N Montuori; A Riccio; G Di Spigna; S Salzano; G Rossi; P Ragno
Journal:  Int J Immunopathol Pharmacol       Date:  2010 Jul-Sep       Impact factor: 3.219

3.  Myopathies related to systemic sclerosis: a case-control study of associated clinical and immunological features.

Authors:  B Ranque; A Bérezné; V Le-Guern; C Pagnoux; Y Allanore; D Launay; E Hachulla; F-J Authier; R Gherardi; A Kahan; J Cabane; L Guillevin; L Mouthon
Journal:  Scand J Rheumatol       Date:  2010-08-20       Impact factor: 3.641

4.  Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis.

Authors:  O Distler; T Pap; O Kowal-Bielecka; R Meyringer; S Guiducci; M Landthaler; J Schölmerich; B A Michel; R E Gay; M Matucci-Cerinic; S Gay; U Müller-Ladner
Journal:  Arthritis Rheum       Date:  2001-11

5.  Insights into the pathogenesis of systemic sclerosis based on the gene expression profile of progenitor-derived endothelial cells.

Authors:  Jérôme Avouac; Nicolas Cagnard; Jörg H Distler; Yoland Schoindre; Barbara Ruiz; Pierre Olivier Couraud; Georges Uzan; Catherine Boileau; Gilles Chiocchia; Yannick Allanore
Journal:  Arthritis Rheum       Date:  2011-11

6.  Downregulation of miR-193b in systemic sclerosis regulates the proliferative vasculopathy by urokinase-type plasminogen activator expression.

Authors:  Naoki Iwamoto; Serena Vettori; Britta Maurer; Matthias Brock; Elena Pachera; Astrid Jüngel; Maurizio Calcagni; Renate E Gay; Michael L Whitfield; Jörg H W Distler; Steffen Gay; Oliver Distler
Journal:  Ann Rheum Dis       Date:  2014-11-10       Impact factor: 19.103

7.  Ulnar artery occlusion is predictive of digital ulcers in SSc: a duplex sonography study.

Authors:  Marc Frerix; Johannes Stegbauer; Duska Dragun; Alexander Kreuter; Stefan M Weiner
Journal:  Rheumatology (Oxford)       Date:  2011-12-20       Impact factor: 7.580

8.  Agonistic autoantibodies directed against the angiotensin II AT1 receptor in patients with preeclampsia.

Authors:  Gerd Wallukat; Dajana Neichel; Eberhard Nissen; Volker Homuth; Friedrich C Luft
Journal:  Can J Physiol Pharmacol       Date:  2003-02       Impact factor: 2.273

9.  Matrix metalloproteinase 12-dependent cleavage of urokinase receptor in systemic sclerosis microvascular endothelial cells results in impaired angiogenesis.

Authors:  Silvia D'Alessio; Gabriella Fibbi; Marina Cinelli; Serena Guiducci; Angela Del Rosso; Francesca Margheri; Simona Serratì; Marco Pucci; Bashar Kahaleh; Pansheng Fan; Francesco Annunziato; Lorenzo Cosmi; Francesco Liotta; Marco Matucci-Cerinic; Mario Del Rosso
Journal:  Arthritis Rheum       Date:  2004-10

10.  Circulating endothelial progenitor cells in systemic sclerosis: association with disease severity.

Authors:  J Avouac; F Juin; J Wipff; P O Couraud; G Chiocchia; A Kahan; C Boileau; G Uzan; Y Allanore
Journal:  Ann Rheum Dis       Date:  2008-01-03       Impact factor: 19.103

View more
  6 in total

Review 1.  A comprehensive framework for navigating patient care in systemic sclerosis: A global response to the need for improving the practice of diagnostic and preventive strategies in SSc.

Authors:  Lesley Ann Saketkoo; Tracy Frech; Cecília Varjú; Robyn Domsic; Jessica Farrell; Jessica K Gordon; Carina Mihai; Nora Sandorfi; Lee Shapiro; Janet Poole; Elizabeth R Volkmann; Monika Lammi; Kendra McAnally; Helene Alexanderson; Henrik Pettersson; Faye Hant; Masataka Kuwana; Ami A Shah; Vanessa Smith; Vivien Hsu; Otylia Kowal-Bielecka; Shervin Assassi; Maurizio Cutolo; Cristiane Kayser; Victoria K Shanmugam; Madelon C Vonk; Kim Fligelstone; Nancy Baldwin; Kerri Connolly; Anneliese Ronnow; Beata Toth; Maureen Suave; Sue Farrington; Elana J Bernstein; Leslie J Crofford; László Czirják; Kelly Jensen; Monique Hinchclif; Marie Hudson; Matthew R Lammi; Jennifer Mansour; Nadia D Morgan; Fabian Mendoza; Mandana Nikpour; John Pauling; Gabriela Riemekasten; Anne-Marie Russell; Mary Beth Scholand; Elise Seigart; Tatiana Sofia Rodriguez-Reyna; Laura Hummers; Ulrich Walker; Virginia Steen
Journal:  Best Pract Res Clin Rheumatol       Date:  2021-09-15       Impact factor: 4.991

Review 2.  The primary care physician in the early diagnosis of systemic sclerosis: the cornerstone of recognition and hope.

Authors:  Lesley Ann Saketkoo; Jeanette H Magnus; Mittie K Doyle
Journal:  Am J Med Sci       Date:  2014-01       Impact factor: 2.378

Review 3.  Endothelial-to-mesenchymal transition in systemic sclerosis.

Authors:  P Cipriani; R Giacomelli; P Di Benedetto; P Ruscitti; O Berardicurti; M Vomero; L Navarini; V Dolo
Journal:  Clin Exp Immunol       Date:  2021-04-18       Impact factor: 5.732

4.  Associations between circulating endostatin levels and vascular organ damage in systemic sclerosis and mixed connective tissue disease: an observational study.

Authors:  Silje Reiseter; Øyvind Molberg; Ragnar Gunnarsson; May Brit Lund; Trond Mogens Aalokken; Pål Aukrust; Thor Ueland; Torhild Garen; Cathrine Brunborg; Annika Michelsen; Aurelija Abraityte; Anna-Maria Hoffmann-Vold
Journal:  Arthritis Res Ther       Date:  2015-08-28       Impact factor: 5.156

Review 5.  Role of NLRP3 inflammasome in systemic sclerosis.

Authors:  Cong Lin; Zhixing Jiang; Ling Cao; Hejian Zou; Xiaoxia Zhu
Journal:  Arthritis Res Ther       Date:  2022-08-16       Impact factor: 5.606

Review 6.  Vascular Remodelling and Mesenchymal Transition in Systemic Sclerosis.

Authors:  Pier Andrea Nicolosi; Enrico Tombetti; Norma Maugeri; Patrizia Rovere-Querini; Silvia Brunelli; Angelo A Manfredi
Journal:  Stem Cells Int       Date:  2016-03-16       Impact factor: 5.443

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.